The Gist Healthcare Podcast

Biogen will stop selling its Alzheimer’s drug, Aduhelm, amid controversy. The Biden Administration makes its initial offers to drug companies on the first ten drugs to be negotiated through Medicare, as courts weigh lawsuits brought by pharmaceutical companies challenging the negotiation process. And, participation in Medicare accountable care organizations is up. That’s coming up on today’s episode of Gist Healthcare Daily. Hosted on Acast. See acast.com/privacy for more information.

Cigna officially offloads its Medicare Advantage business to Health Care Service Corporation. The Biden Administration will negotiate on behalf of states to provide a groundbreaking gene therapy for Medicaid beneficiaries with sickle cell disease. And, the Dana Farber Cancer Institute is issuing corrections and retracting some research papers amid falsification allegations. That’s coming up on today’s episode of Gist Healthcare Daily. Hosted on Acast. See acast.com/privacy for more information.

Fitch Ratings says lower operating margins at nonprofit hospitals may be here to stay. The Biden Administration wants stakeholder input on making Medicare Advantage more transparent. And, a new study examines a small number of transmissible Alzheimer’s cases tied to a medical treatment that’s no longer used. That’s coming up on today’s episode of Gist Healthcare Daily. Hosted on Acast. See acast.com/privacy for more information.

Federal regulators sue to block Novant Health’s purchase of two Community Health Systems hospitals in North Carolina. Insurers say that the No Surprises Act prevented 10 million surprise bills for patients in the first nine months of 2023. And, North Carolina says it will no longer pay for popular–and costly–weight loss drugs for state employees. That’s coming up on today’s episode of Gist Healthcare Daily. Hosted on Acast. See acast.com/privacy for more information.

Congressional lawmakers established a new arbitration process when they passed the No Surprises Act in December 2020. Since April 2022, payers and providers have been able to have a third-party settle payment disputes over out-of-network claims. However, the process has been bogged down by exceedingly high caseloads and legal challenges. On today’s episode of Gist Healthcare Daily, Matthew Fiedler, Senior Fellow at the Brookings Institution, joins the podcast to talk more about how the process has fared overall since its launch.  Hosted on Acast. See acast.com/privacy for more information.

The Biden Administration releases voluntary cybersecurity goals for healthcare providers. It was a record-breaking year for health plan enrollment on the Affordable Care Act exchanges. And, a majority of rural hospitals have had to cut labor and delivery services for pregnant people. That’s coming up on today’s episode of Gist Healthcare Daily. Hosted on Acast. See acast.com/privacy for more information.

Walgreens is reportedly exploring a sale of its specialty pharmacy business, Shields Health. Instacart expands its reach into the home care sector. And, the mortality rate among hospital-at-home patients is low, according to a recent study. That’s coming up on today’s episode of Gist Healthcare Daily. Hosted on Acast. See acast.com/privacy for more information.

Bloomberg Philanthropies will invest $250 million to launch healthcare-focused high schools to address workforce shortages. Younger people are being diagnosed with cancer at higher rates, according to recent studies. And, funding for digital health projects is at its lowest point since 2019. That’s coming up on today’s episode of Gist Healthcare Daily. Hosted on Acast. See acast.com/privacy for more information.

Intermountain’s Saltzer Health faces a shutdown if it can’t find a buyer. Physicians at two Allina Health hospitals get the green light to unionize. And, disproportionate share hospitals will continue to receive payments–temporarily–as Congress averts another government shutdown in the short term. That’s coming up on today’s episode of Gist Healthcare Daily. Hosted on Acast. See acast.com/privacy for more information.

Hospitals and health insurers were more compliant with price transparency laws and regulations in 2023, according to healthcare price data company Turquoise Health. Carol Skenes, Principal Strategist at Turquoise, joins the podcast to talk more about what this data means for consumers and the healthcare industry.  Hosted on Acast. See acast.com/privacy for more information.